BR9508765A - Vacina viva para o tratamento de tumores - Google Patents
Vacina viva para o tratamento de tumoresInfo
- Publication number
- BR9508765A BR9508765A BR9508765A BR9508765A BR9508765A BR 9508765 A BR9508765 A BR 9508765A BR 9508765 A BR9508765 A BR 9508765A BR 9508765 A BR9508765 A BR 9508765A BR 9508765 A BR9508765 A BR 9508765A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- cells
- pct
- tumour
- cell
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 9
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 229940030156 cell vaccine Drugs 0.000 abstract 3
- 230000003308 immunostimulating effect Effects 0.000 abstract 3
- 210000004881 tumor cell Anatomy 0.000 abstract 3
- 108020004440 Thymidine kinase Proteins 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000010353 genetic engineering Methods 0.000 abstract 2
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001136—Cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5418—IL-7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5156—Animal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4431401A DE4431401A1 (de) | 1994-08-24 | 1994-08-24 | Lebendvakzine gegen Tumorerkrankungen |
| PCT/DE1995/001164 WO1996005866A2 (de) | 1994-08-24 | 1995-08-18 | Lebendvakzine zur behandlung von tumorerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9508765A true BR9508765A (pt) | 1997-11-11 |
Family
ID=6527332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9508765A BR9508765A (pt) | 1994-08-24 | 1995-08-18 | Vacina viva para o tratamento de tumores |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6039941A (pt) |
| EP (1) | EP0777499B1 (pt) |
| JP (1) | JP2975117B2 (pt) |
| KR (1) | KR970705416A (pt) |
| AT (1) | ATE228016T1 (pt) |
| AU (1) | AU688101B2 (pt) |
| BR (1) | BR9508765A (pt) |
| CA (1) | CA2198234A1 (pt) |
| DE (3) | DE4431401A1 (pt) |
| DK (1) | DK0777499T3 (pt) |
| ES (1) | ES2187568T3 (pt) |
| PT (1) | PT777499E (pt) |
| WO (1) | WO1996005866A2 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7361332B2 (en) | 1995-03-17 | 2008-04-22 | The Regents Of The University Of California | Treating tumors using implants comprising combinations of allogeneic cells |
| US5952221A (en) * | 1996-03-06 | 1999-09-14 | Avigen, Inc. | Adeno-associated virus vectors comprising a first and second nucleic acid sequence |
| DE19626830A1 (de) * | 1996-07-04 | 1998-01-08 | Max Delbrueck Centrum | Konditionales Immortalisationsverfahren für humane Tumorzellen zur Herstellung einer Vakzine |
| US6277368B1 (en) | 1996-07-25 | 2001-08-21 | The Regents Of The University Of California | Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine |
| WO1998016238A2 (en) | 1996-10-11 | 1998-04-23 | The Regents Of The University Of California | Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| AUPQ755300A0 (en) * | 2000-05-17 | 2000-06-08 | Monash University | Immune potentiating compositions |
| AU785241B2 (en) * | 2000-05-17 | 2006-11-23 | Cancure Limited | Immune potentiating compositions |
| WO2004004771A1 (ja) * | 2002-07-03 | 2004-01-15 | Ono Pharmaceutical Co., Ltd. | 免疫賦活組成物 |
| GB0223696D0 (en) * | 2002-10-14 | 2002-11-20 | Ml Lab Plc | Improved immunotherapy |
| JP2006096663A (ja) * | 2002-10-17 | 2006-04-13 | Sangaku Renkei Kiko Kyushu:Kk | 癌遺伝子ワクチン |
| GB0227989D0 (en) * | 2002-12-02 | 2003-01-08 | Imp College Innovations Ltd | Chimaeric molecules |
| EP1667701A4 (en) * | 2003-09-26 | 2007-02-14 | Univ Miami | TUMOR VACCINE |
| BRPI0418157A (pt) | 2003-12-30 | 2007-04-17 | Mologen Ag | terapêutica de tumores alogênicos |
| EA200700598A1 (ru) | 2007-03-07 | 2007-12-28 | Петр Генриевич ЛОХОВ | Противоопухолевая вакцина, способ получения противоопухолевой вакцины и способ проведения противоопухолевой иммунотерапии |
| CN101855549A (zh) | 2007-09-12 | 2010-10-06 | 耶达研究及发展有限公司 | 在免疫豁免部位内治疗肿瘤的方法 |
| RU2407789C2 (ru) * | 2008-07-25 | 2010-12-27 | Виктор Владимирович Кешелава | Способ получения живой клеточной вакцины для профилактики рака молочных желез |
| EA200801751A1 (ru) * | 2008-08-26 | 2009-02-27 | Петр Генриевич ЛОХОВ | Способ получения противоопухолевой вакцины |
| WO2010045573A2 (en) | 2008-10-17 | 2010-04-22 | University Of Miami | Tumor vaccine |
| CN111743884A (zh) * | 2019-03-26 | 2020-10-09 | 深圳先进技术研究院 | 苄丝肼或其衍生物的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI91713C (fi) * | 1992-04-23 | 1994-08-10 | Axidental Oy | Uusia bioaktiivisia pinnotteita ja niiden valmistus ja käyttö |
| EP0637966B1 (en) * | 1992-05-01 | 1997-08-27 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Bystander effect tumoricidal therapy |
| WO1994004196A1 (en) * | 1992-08-14 | 1994-03-03 | Imperial Cancer Research Technology Limited | Tumour therapy |
-
1994
- 1994-08-24 DE DE4431401A patent/DE4431401A1/de not_active Withdrawn
-
1995
- 1995-08-18 JP JP8507710A patent/JP2975117B2/ja not_active Expired - Fee Related
- 1995-08-18 DE DE19580890T patent/DE19580890D2/de not_active Ceased
- 1995-08-18 ES ES95929003T patent/ES2187568T3/es not_active Expired - Lifetime
- 1995-08-18 US US08/793,104 patent/US6039941A/en not_active Expired - Fee Related
- 1995-08-18 WO PCT/DE1995/001164 patent/WO1996005866A2/de not_active Ceased
- 1995-08-18 BR BR9508765A patent/BR9508765A/pt unknown
- 1995-08-18 EP EP95929003A patent/EP0777499B1/de not_active Expired - Lifetime
- 1995-08-18 DE DE59510466T patent/DE59510466D1/de not_active Expired - Lifetime
- 1995-08-18 PT PT95929003T patent/PT777499E/pt unknown
- 1995-08-18 KR KR1019970701175A patent/KR970705416A/ko not_active Ceased
- 1995-08-18 AT AT95929003T patent/ATE228016T1/de not_active IP Right Cessation
- 1995-08-18 DK DK95929003T patent/DK0777499T3/da active
- 1995-08-18 AU AU32531/95A patent/AU688101B2/en not_active Ceased
- 1995-08-18 CA CA002198234A patent/CA2198234A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2975117B2 (ja) | 1999-11-10 |
| EP0777499A1 (de) | 1997-06-11 |
| JPH10505339A (ja) | 1998-05-26 |
| ATE228016T1 (de) | 2002-12-15 |
| CA2198234A1 (en) | 1996-02-29 |
| EP0777499B1 (de) | 2002-11-20 |
| DK0777499T3 (da) | 2003-03-17 |
| DE59510466D1 (de) | 2003-01-02 |
| ES2187568T3 (es) | 2003-06-16 |
| WO1996005866A3 (de) | 1996-04-11 |
| PT777499E (pt) | 2003-03-31 |
| DE4431401A1 (de) | 1996-02-29 |
| AU688101B2 (en) | 1998-03-05 |
| US6039941A (en) | 2000-03-21 |
| AU3253195A (en) | 1996-03-14 |
| MX9701384A (es) | 1998-03-31 |
| KR970705416A (ko) | 1997-10-09 |
| WO1996005866A2 (de) | 1996-02-29 |
| DE19580890D2 (de) | 1997-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9508765A (pt) | Vacina viva para o tratamento de tumores | |
| AP2003002937A0 (en) | One dose vaccination with mycoplasma hyopneumoniae | |
| ES2167365T3 (es) | Vectores adenovirales de origen animal y utilizacion en terapia genica. | |
| MX9700229A (es) | Vacuna de polinucleotido para virus de papiloma. | |
| EP1322755A4 (en) | BY PHAGENDISPLAY IDENTIFIED TARGETS OF PEOPLE AND MOUSE | |
| GR3020557T3 (en) | Oligonucleotide alkylphosphonates and alkylphosphonothioates. | |
| DK0784483T3 (da) | Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul | |
| DE3878468D1 (de) | Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus. | |
| NO20044940L (no) | Rekombinant poxvirus som uttrykker homologe gener innsatt i det poxvirale genomet | |
| MXPA03011815A (es) | Vacuna de micoplasma bovis y metodos para reducir la neumonia en animales. | |
| DE69434244D1 (de) | Verbesserte krebstherapie | |
| BRPI0418157A (pt) | terapêutica de tumores alogênicos | |
| MY209484A (en) | Cpg amphiphiles and uses thereof | |
| FR2746110B1 (fr) | Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants | |
| BR0313413A (pt) | Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| CY1111522T1 (el) | 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο | |
| DE69635472D1 (de) | Impfstoff gegen Geflügelkokzidose | |
| BR0311371A (pt) | Composições para uso terapêutico compreendendo uma vitamina, um sal de metal e insulina ou um hormÈnio de crescimento | |
| BR0209145A (pt) | Vacina contra varìola | |
| MX2023005154A (es) | Nanopartículas codificadas de adn y método de uso de las mismas como una vacuna contra la enfermedad corona virus (covid-19). | |
| BR0110791A (pt) | Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo | |
| BRPI0112407B8 (pt) | uso de cepas de parapoxvírus ovis para produzir medicamentos antivirais e medicamentos contra câncer | |
| MX9708615A (es) | Terapia de genes animales. | |
| UA90838C2 (ru) | Рекомбинантный поксвирус, который экспрессирует гомологические гены, вставленные в поксвирусный геном |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |